• CDB double dips with euro/dollar combo

    China Development Bank Hong Kong gave investors a dual option Thursday, issuing a five year dollar bond and a three year euro deal, finding space in a crowded market that saw six other trades hit the screens.

    • 12:00 PM
  • Bonds make frantic dash ahead of November

    Seven deals launched Thursday as issuers came out in force to raise money ahead what is expected to be greater market uncertainty in November.

    • 27 Oct 2016
  • StanChart opens books to SDR bond

    China’s domestic bond market is poised for another landmark transaction with Standard Chartered Bank (Hong Kong) opening books to a special drawing rights-denominated bond on Tuesday.

    • 25 Oct 2016
  • Kaboom! CR Pharma listing fetches $1.8bn

    China Resources Pharmaceutical Group priced its Hong Kong IPO near the middle of expectations on Friday morning, raising HK$14bn ($1.8bn) after investors stormed into the trade.

    • 21 Oct 2016
  • StanChart unveils bank line-up for SDR bond

    Standard Chartered Bank (Hong Kong) has unveiled the syndicate for its special drawing rights-denominated bond.

    • 20 Oct 2016
  • CR Pharma narrows range on HK$15bn IPO

    China Resources Pharmaceutical Group has tightened the price range on its IPO, putting it on track to raise up to HK$14.8bn ($1.9bn), according to a banker on the deal.

    • 20 Oct 2016
  • Investors after strong dose of CR Pharma IPO

    China Resources Pharmaceutical Group is proving a hit with global investors, as its HK$15.7bn ($2.0bn) Hong Kong IPO is heavily oversubscribed, according to a banker at one of the leads.

    • 18 Oct 2016
  • Show of strength for CR Pharma as $2bn IPO launches

    China Resources Pharmaceutical Group’s HK$15.7bn ($2.0bn) Hong Kong IPO got off to a flying start this week, with books covered and support from high profile cornerstone investors giving it momentum.

    • 13 Oct 2016
  • Updated: CR Pharma $2bn IPO nets big name cornerstones

    China Resources Pharmaceutical Group has lined up eight cornerstone investors for its HK$15.6bn ($2.0bn) Hong Kong IPO, with the group agreeing to buy $916m worth of shares.

    • 12 Oct 2016
  • CR Pharma sets price range for $2bn HK IPO

    China Resources Pharmaceutical Group will raise as much as HK$15.6bn ($2.0bn) via a Hong Kong IPO after firming up the price range.

    • 11 Oct 2016
  • Shandong International Trust stokes IPO plans

    Shandong International Trust Co has submitted an IPO application to the Hong Kong Stock Exchange for an expected $300m offering.

    • 04 Oct 2016

Panda Bonds Top Arrangers

Rank Arranger Total Volume Rmb (m) No. of Deals Share % by Volume
1 Bank of China (BOC) 7,500 5 21.01
2 Agricultural Bank of China (ABC) 4,000 2 11.20
2 Everbright Securities 4,000 1 11.20
4 Industrial and Commercial Bank of China (ICBC) 3,500 2 9.80
5 HSBC 3,000 2 8.40

Bookrunners of Asia-Pac (ex-Japan) ECM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 26 Oct 2016
1 CITIC Securities 15,417.46 59 6.69%
2 Morgan Stanley 11,809.74 49 5.12%
3 GF Securities Co Ltd 11,402.65 45 4.95%
4 Deutsche Bank 8,930.26 36 3.87%
5 China Securities Co Ltd 8,697.57 46 3.77%

Bookrunners of Asia Pacific (ex-Japan) G3 DCM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 25 Oct 2016
1 HSBC 25,655.98 155 9.54%
2 Citi 24,170.03 132 8.99%
3 Bank of America Merrill Lynch 21,409.23 104 7.97%
4 JPMorgan 18,713.00 109 6.96%
5 Goldman Sachs 12,065.00 52 4.49%